Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H9ClF3N3O2S2 |
| Molecular Weight | 419.829 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FC(F)(F)C1=C(Cl)C=CC(=C1)S(=O)(=O)C2=CC=C(C=C2)N3C=NNC3=S
InChI
InChIKey=BJWHWZOMLHXKPF-UHFFFAOYSA-N
InChI=1S/C15H9ClF3N3O2S2/c16-13-6-5-11(7-12(13)15(17,18)19)26(23,24)10-3-1-9(2-4-10)22-8-20-21-14(22)25/h1-8H,(H,21,25)
| Molecular Formula | C15H9ClF3N3O2S2 |
| Molecular Weight | 419.829 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 14:25:10 GMT 2023
by
admin
on
Sat Dec 16 14:25:10 GMT 2023
|
| Record UNII |
L05II461IJ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
704119
Created by
admin on Sat Dec 16 14:25:10 GMT 2023 , Edited by admin on Sat Dec 16 14:25:10 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
139507438
Created by
admin on Sat Dec 16 14:25:10 GMT 2023 , Edited by admin on Sat Dec 16 14:25:10 GMT 2023
|
PRIMARY | |||
|
L05II461IJ
Created by
admin on Sat Dec 16 14:25:10 GMT 2023 , Edited by admin on Sat Dec 16 14:25:10 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
TARGET->INHIBITOR OF AGGREGATION |
Reduced the accumulation of a-syn in vivo, and upregulated LC3 expression, both in vitro and in vivo, suggests that NPT520-34 may influence protein clearance mechanisms for pathological proteins.
|
||
|
|
TARGET->ACTIVATOR OF EXPRESSION |
Increases expression may be responsible for the increased clearance of ALPHA-SYNUCLEIN aggregates.
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| BRAIN/PLASMA RATIO | PHARMACOKINETIC |
|
|
|||